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Background: Predictive modeling is fundamental to transforming large clinical data sets, or “big clinical data,” into 
actionable knowledge for various healthcare applications. Machine learning is a major predictive modeling approach, 
but two barriers make its use in healthcare challenging. First, a machine learning tool user must choose an algo-
rithm and assign one or more model parameters called hyper-parameters before model training. The algorithm and 
hyper-parameter values used typically impact model accuracy by over 40 %, but their selection requires many labor-
intensive manual iterations that can be difficult even for computer scientists. Second, many clinical attributes are 
repeatedly recorded over time, requiring temporal aggregation before predictive modeling can be performed. Many 
labor-intensive manual iterations are required to identify a good pair of aggregation period and operator for each 
clinical attribute. Both barriers result in time and human resource bottlenecks, and preclude healthcare administrators 
and researchers from asking a series of what-if questions when probing opportunities to use predictive models to 
improve outcomes and reduce costs.
Methods: This paper describes our design of and vision for PredicT-ML (prediction tool using machine learning), a 
software system that aims to overcome these barriers and automate machine learning model building with big clini-
cal data.
Results: The paper presents the detailed design of PredicT-ML.
Conclusions: PredicT-ML will open the use of big clinical data to thousands of healthcare administrators and 
researchers and increase the ability to advance clinical research and improve healthcare.
Keywords: Machine learning, Automatic algorithm selection, Automatic hyper-parameter value selection, 
Automated temporal aggregation, Big clinical data
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Background
Challenges in building machine learning predictive models 
with big clinical data
Predictive modeling is vital to transforming large clini-
cal data sets, or “big clinical data,” into actionable knowl-
edge for various healthcare applications. Predictive 
models can guide clinical decision making and personal-
ized medicine. For example, by determining an asthma 
patient’s risk of hospitalization within the next year, we 
can enroll patients at high risk in an asthma case man-
agement program [1].
As a major approach to predictive modeling, machine 
learning studies computer algorithms that improve auto-
matically through experience, such as decision tree, ran-
dom forest, neural network, and support vector machine 
[2]. A recent survey showed that 15  % of hospitals use 
machine learning predictive models for clinical purposes, 
and many more are considering it [3]. Historically, most 
machine learning algorithms were criticized for provid-
ing no explanation for their prediction results. Recently, 
a new method was developed to automatically explain 
prediction results of any machine learning model without 
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losing accuracy [1, 4]. However, machine learning still 
presents two major challenges to use in healthcare, both 
badly supported by existing software such as Weka [5], 
KNIME, R, and RapidMiner [6].
Challenge 1: efficiently and automatically selecting 
algorithms and hyper‑parameter values
Every machine learning algorithm has two kinds of model 
parameters (see Table  1): ordinary parameters auto-
matically learned or optimized in model training, and 
hyper-parameters manually set by the user of a machine 
learning tool before model training. Given a modeling 
problem like predicting whether an adult will develop 
type 2 diabetes, an analyst builds a model manually and 
iteratively. First, the analyst selects an algorithm from 
many applicable algorithms like the 39 classification algo-
rithms in Weka [5]. Second, the analyst sets the chosen 
algorithm’s hyper-parameter values. Third, the analyst 
trains the model to automatically optimize the chosen 
algorithm’s ordinary parameters. If model accuracy is 
insufficient, the analyst changes hyper-parameter values 
and/or algorithm and re-builds the model. This process is 
iterated until the analyst obtains a model with sufficient 
accuracy, no longer has time, or cannot improve model 
accuracy. Numerous combinations of algorithms and 
hyper-parameter values result in hundreds or thousands 
of labor-intensive manual iterations to build a model, 
which can be difficult even for experts in machine learn-
ing [7].
The algorithm and hyper-parameter values used affect 
model accuracy. Thornton et  al. [7] showed for the 39 
algorithms in Weka, the effect on model accuracy is on 
average 46 % on 21 data sets and 94 % on one data set. 
Even if considering only a few common algorithms such 
as support vector machine and random forest, the effect 
is still >20 % on 14 of 21 data sets. Moreover, the effective 
combination of an algorithm and hyper-parameter values 
varies by modeling problem. Researchers have explored 
automatic search for algorithms and hyper-parameter 
values [8]. Rising evidence shows that automatic search 
methods can obtain equivalent or better results than 
machine learning experts’ careful manual tuning [9, 10]. 
However, when many algorithms are considered, previ-
ous efforts such as MLbase [11, 12], hyperopt-sklearn 
[10], and Auto-WEKA [7] cannot quickly select good 
algorithms and hyper-parameter values on a large data 
set and have limited usefulness.
A key barrier to automatic search is the long time 
required to evaluate a combination of an algorithm and 
hyper-parameter values on the full data set. For instance, 
for the champion ensemble model of the Practice Fusion 
diabetes classification competition [13], it takes 2  days 
on a modern computer to train the model once on 9948 
patients with 133 features, a.k.a. input or independent 
variables. To identify an effective combination, prior 
automation efforts evaluate numerous combinations 
on the full data set. Even when aborting long-running 
tests, ignoring ensembles of >5 base models, and allow-
ing rather incomplete search that all impact search 
result quality, search time can be several days on a data 
set containing several thousand rows (data instances) 
and several dozen attributes [7]. Practically, search time 
can be thousands of times longer for four reasons: (1) 
Machine learning is an iterative process. If a set of clini-
cal parameters generates low prediction accuracy, the 
analyst can add other clinical parameters that may be 
predictive. Every iteration needs a new search for algo-
rithms and hyper-parameter values. (2) Ensembles of 
many base models often achieve higher accuracy. An 
ensemble model’s training time grows linearly with the 
number of base models. (3) A data set can contain many 
rows, e.g., from several healthcare systems. (4) A data set 
can have many attributes, e.g., obtained from genomic 
and/or textual data. The execution time of an algorithm 
frequently increases superlinearly with the number of 
rows and at least linearly with the number of attributes. 
A long search time precludes healthcare administrators 
and researchers from asking a series of what-if questions 
when probing opportunities to use predictive models to 
improve outcomes and reduce costs. An example ques-
tion is: can we predict asthma readmission accurately 
enough to apply an intervention effectively? Moreover, 
personalized medicine requires solving many predictive 
modeling problems for various diseases and outcomes, 
where search time is a bottleneck even with a computer 
cluster. Regardless of whether search is conducted auto-
matically or manually, a slow search speed often forces 
the search process to be stopped prematurely, leading 
to suboptimal model accuracy and outcomes of using 
models.
Table 1 Some example machine learning (ML) algorithms, 
ordinary parameters and hyper-parameters




Random forest Input variable and 
threshold value 
selected at every 
internal node of a 
decision tree
Number of decision 
trees, number of 
input variables to 
evaluate at every 
internal node of a 
decision tree
Support vector  
machine
Support vectors, 
lagrange multiplier  
for every support 
vector
Kernel to use, degree 
of a polynomial 
kernel, ε for round-off 
error, regularization 
constant C, tolerance 
parameter
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Challenge 2: efficiently automating temporal aggregation 
of clinical attributes
Many clinical attributes are repeatedly recorded over 
time, requiring temporal aggregation before machine 
learning. For example, weight at each visit is aggregated 
to obtain a patient’s average weight over the past year. 
For each attribute, computing a temporal aggregate value 
requires specifying a pair of aggregation period and oper-
ator (e.g., average, maximum, count). Usually, healthcare 
professionals help specify pairs and computer scientists 
conduct computation. Many pairs can be clinically mean-
ingful. Those producing high accuracy vary by predictive 
modeling problem and are often unknown beforehand.
Given a predictive modeling problem, an analyst manu-
ally identifies one or more temporal aggregation periods 
and operators for every clinical attribute, then builds 
the model. If model accuracy is insufficient, the analyst 
changes aggregation periods and operators for some 
attributes and re-builds the model. This labor-intensive 
process requires interactions between healthcare pro-
fessionals and computer scientists and is often repeated 
hundreds of times, causing another time and human 
resource bottleneck, particularly when healthcare pro-
fessionals have limited time for meeting and discussion. 
Also, no complete list of aggregation operators is avail-
able, requiring caution to not miss effective operators.
Our new software
New methods are needed to efficiently automate build-
ing machine learning predictive models with big clinical 
data. To fill the gap, in this paper we describe the design 
of new software called PredicT-ML (prediction tool using 
machine learning) to automate the process. Conceptually, 
PredicT-ML is an automated version of Weka [5] for big 
clinical data, with added support for automated temporal 
aggregation. Computer scientists with advanced machine 
learning skills are scarce in healthcare institutes. PredicT-
ML can be used by computer scientists when they work 
with healthcare administrators and researchers, can save 
effort for both healthcare professionals and computer sci-
entists, reduce computing time, enable fast turnaround, 
lower the machine learning skill required of computer 
scientists, and increase their capacity of serving health-
care administrators’ and researchers’ predictive modeling 
needs. Compared to the current manual approach, Pre-
dicT-ML performs more tests systematically and can pro-
duce models achieving accuracy closer to the theoretical 
limit.
PredicT-ML provides an intuitive graphical user 
interface. The user can optionally specify feature selec-
tion techniques and machine learning algorithms to be 
explored, and/or some features that must be included in 
the model. PredicT-ML will efficiently and automatically 
select algorithms, feature selection techniques, hyper-
parameter values, and temporal aggregation periods and 
operators. In real time, PredicT-ML displays projected 
model accuracy and estimated patient outcomes of using 
models as a function of time allotted for model building. 
If projections are unpromising, users can abort the auto-
matic selection process, add more clinical parameters, 
and restart. Or, users can consider other ways of using 
predictive models to improve outcomes and reduce costs, 
e.g., by addressing another disease or prediction target. 
This enables users to rapidly ask a series of what-if ques-
tions when probing opportunities for improving health-
care, as even with our efficient techniques, automatic 
selection on a large data set can still take a relatively long 
time (e.g., a few hours).
PredicT-ML can run on a computer cluster for scal-
able parallel processing and perform fast iterative 
machine learning. For instance, an electronic medi-
cal record includes hundreds of thousands of clinical 
parameters [14, p. 56]. An analyst usually begins the 
analytical process with a few clinical parameters, then 
uses PredicT-ML to iteratively add more clinical param-
eters for analysis until reaching sufficient prediction 
accuracy. PredicT-ML can export temporally aggregated 
data in standard file formats such as comma-separated 
values (CSV) for use by other software systems, making 
PredicT-ML foundationally and structurally interoper-
able [15]. Internally, PredicT-ML keeps data in relational 
table formats accepted by many software packages. This 
will facilitate adding new functions such as visualization, 
making PredicT-ML extensible.
PredicT-ML is generalizable to various diseases. Pre-
dicT-ML’s design does not rely on any specific property 
of a particular disease, patient population, or clinical data 
set. PredicT-ML is generalizable to many data sources 
by supporting common data models (e.g., OMOP [16]) 
and their associated standardized terminologies used 
by many healthcare systems. Once attributes needed to 
solve a clinical predictive modeling problem are avail-
able in one of the common data models or in a structured 
data set, PredicT-ML can be used to build models. This 
interoperability enables data integration and helps build 
machine learning predictive models with big clinical data 
from multiple healthcare systems.
Innovation
Existing machine learning tools are not tailored to 
healthcare researchers’ needs. This work addresses gaps 
in existing software and is innovative for the following 
reasons:
1. We present the first software to automate building 
machine learning predictive models with big clini-
Page 4 of 16Luo  Health Inf Sci Syst  (2016) 4:5 
cal data and to support fast iterative machine learn-
ing. The software will enable healthcare administra-
tors and researchers to rapidly ask a series of what-if 
questions when probing opportunities to use predic-
tive models to improve outcomes and reduce costs 
for various diseases and patient populations. Existing 
machine learning tools cannot do this.
2. We present a new method to automatically select 
algorithms, feature selection techniques, and hyper-
parameter values for a given machine learning prob-
lem more quickly than current methods.
3. We present the first method to automatically and 
efficiently select temporal aggregation periods and 
operators for clinical attributes.
4. We present a new method to project in real time 
model accuracy and estimated patient outcomes of 
using models as a function of time allotted for model 
building. This is the first time continuous feedback is 
provided during automatic model selection.
Related work
Several dozen methods have been published on auto-
matically selecting machine learning algorithms and/
or hyper-parameter values. Few of these methods have 
been fully implemented and can handle many algorithms 
and any number of hyper-parameter value combinations. 
None is efficient for large data sets or optimized for a 
computer cluster. The automatic machine learning model 
selection method described in this paper addresses these 
methods’ limitations. A summary comparison of these 
methods is provided in our paper [17]. A detailed review 
of these methods is provided in our paper [8].
Many clinical data are stored in the EAV format [18]. 
They often must be pivoted into denormalized relational 
table formats before conducting analysis. We previously 
developed three techniques for improving efficiency of 
pivoting [19] and showed how to use MapReduce [20] to 
implement them on Spark [17]. PredicT-ML uses a simi-
lar approach to implement temporal aggregation opera-
tors on Spark.
PredicT-ML projects in real time model accuracy and 
estimated patient outcomes of using models as a func-
tion of time allotted for model building. This is a form of 
progress indicator. Progress indicators are widely used 
in software systems and have been used before for data-
base SQL queries [21, 22], program compilation [23], and 
MapReduce jobs [24, 25]. Traditional progress indicators 
continuously estimate remaining task execution time. In 
comparison, PredicT-ML continuously projects trend 
curves.
Haug et al. developed a semi-automated method to sys-
tematically compile risk factors for a disease [26], and a 
tool that first uses compiled knowledge to automatically 
retrieve data from a clinical data warehouse and organ-
ize them without performing temporal aggregation, then 
uses a machine learning algorithm chosen by the user to 
build predictive models for the disease [27, 28]. It would 
be an interesting area for future work to investigate using 
natural language processing techniques to semi-automat-
ically compile medical knowledge that PredicT-ML needs 
for automating temporal aggregation.
Methods
PredicT-ML is built on top of several existing big data 
software systems, allowing it to run on a single computer 
or on a computer cluster for parallel processing. Hadoop 
[29] and Spark [30] are major open source big data soft-
ware systems supporting the MapReduce framework [20] 
for distributed computing. MapReduce uses the Map and 
Reduce functions. The Map function turns an input item 
into zero or more key-value pairs. The Reduce function 
turns a key and its list of linked values into zero or more 
key-value pairs, which can be of another type. Hadoop 
stores data in the Hadoop distributed file system and 
typically executes jobs by repeatedly reading and writing 
data from and to disk, incurring large overhead [31]. To 
address Hadoop’s limitations and improve performance, 
Spark [30, 31] was built atop of the Hadoop distributed 
file system and performs most operations in memory. 
Spark SQL [32, 33] supports a large part of structured 
query language (SQL) on top of Spark. MLlib [11, 34, 
35] is the distributed machine learning library of Spark. 
Spark can run machine learning algorithms more than 
100 times faster than Hadoop [32]. PredicT-ML is devel-
oped using the Spark package and new techniques to 
overcome existing software’s limitations. The Spark pack-
age includes Spark SQL and MLlib.
Figure  1 compares the current approach of building 
models to PredicT-ML’s. During machine learning on big 
clinical data, the following steps are executed sequen-
tially: temporally aggregate clinical attributes, select 
algorithms and hyper-parameter values, build models, 
and evaluate models. PredicT-ML supports these steps 
(Fig. 2). The first step is optional, e.g., if the medical data 
set contains no repeatedly recorded clinical attribute. 
PredicT-ML is built using the open source software sys-
tems Weka and Spark including Spark SQL and MLlib. 
Each one either is written in Java or supports a Java appli-
cation programming interface. PredicT-ML is written 
in Java so it can interface with and call the functions in 
these software systems.
PredicT-ML integrates machine learning functions 
of Weka [5] and MLlib [11, 34, 35] by calling the Java 
application programming interface and/or modifying 
source code of Weka and MLlib. Weka is a widely used 
open source machine learning and data mining toolkit 
Page 5 of 16Luo  Health Inf Sci Syst  (2016) 4:5 
including many standard machine learning algorithms 
and feature selection techniques. distributedWekaSpark 
[36] is Weka’s distributed computing package for Spark. 
MLlib implements a subset of the algorithms and feature 
selection techniques supported by Weka. PredicT-ML 
supports all algorithms and feature selection techniques 
in Weka. For an algorithm or technique implemented 
in MLlib, PredicT-ML uses MLlib’s implementation 
that integrates with Spark more effectively than distrib-
utedWekaSpark’s implementation [36]. For any other 
algorithm or technique, PredicT-ML uses distributed-
WekaSpark’s implementation.
PredicT-ML provides an intuitive graphical user inter-
face. In the input interface, the user provides the medical 
data set’s storage location, such as the name of a file in 
the Hadoop distributed file system, a comma-separated 
values (CSV) file in the local file system, or a table in a 
relational database. PredicT-ML will automatically load 
the medical data set into Spark before machine learning.
The graphical user interface of Weka [5] supports fea-
ture selection (optional) and model building and evalu-
ation. The user specifies in the input interface the data 
file, independent and dependent variables, and machine 
learning algorithm and hyper-parameter values. After 
clicking “Start,” Weka constructs the model and displays 
its performance metrics. The graphical user interface of 
PredicT-ML for machine learning works in a similar way 
with two major differences. First, in the input interface of 
Weka, the user has to choose an algorithm before model 
building. Similar to Auto-WEKA [7], PredicT-ML regards 
the identification of a feature selection technique to be a 
hyper-parameter and automatically selects the algorithm, 
feature selection technique, and hyper-parameter val-
ues. The user can override PredicT-ML’s choice. Second, 
to help the user track progress of the automatic model 
selection process, PredicT-ML displays a curve showing 
the highest accuracy achieved over time. At any time, the 
user can stop the process and ask PredicT-ML to output 
the most accurate model built.
By default, PredicT-ML considers all input variables, 
feature selection techniques, and machine learning algo-
rithms. The user can choose to specify, in the input inter-
face, a portion of input variables that has to be used in the 
model. Then feature selection will be employed only to 
the remaining input variables. Also, the user can choose 
to specify algorithms and/or feature selection techniques 
to be examined.
Results and discussion
This part of the paper presents the detailed design of Pre-
dicT-ML and is organized as follows. We first describe 
three methods used in PredicT-ML (Fig.  2), one to effi-
ciently automate selection of machine learning algo-
rithms and hyper-parameter values, one to efficiently 
automate selection of temporal aggregation periods and 
operators for clinical attributes, and one to project in real 
time model accuracy and estimated patient outcomes 
of using models as a function of time allotted for model 
building. Then we describe our preliminary results on 
the initial implementation and performance evaluation 
of our draft method for automatically selecting machine 
learning algorithms and hyper-parameter values [17] on a 
single computer. Finally, we describe our evaluation plan 
for PredicT-ML.
A method to efficiently automate selection of machine 
learning algorithms and hyper‑parameter values
As shown in our review paper [8], few published auto-
matic selection methods for machine learning algorithms 
and hyper-parameter values [7, 10, 37] have been fully 
implemented and can handle many algorithms and any 
number of hyper-parameter value combinations. All of 
these methods use the Auto-WEKA automatic selection 
approach [7], but none is efficient for large data sets or 
optimized for a computer cluster.
To address existing methods’ inefficiency, we recently 
proposed a draft method to quickly find an effective 
combination of a machine learning algorithm and hyper-
parameter values for a given modeling problem when 
many algorithms are considered [17, 38]. The method 
Fig. 1 The current approach of building machine learning models vs. PredicT-ML’s
Fig. 2 Architecture of PredicT-ML
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performs progressive sampling [39], filtering, and fine-
tuning to quickly reduce the search space. Our idea is 
to perform fast trials on small samples of the data set to 
remove as many unpromising combinations as soon as 
possible, and to allocate more resources to fine-tuning 
promising ones. We use a limited random sample of the 
data set to evaluate various combinations and identify 
several promising ones as the foundation for a reduced 
search space. A combination is regarded as promising if a 
model trained using it and the sample achieves accuracy 
above an initial threshold. We then expand the sample, 
increase the accuracy threshold, evaluate and fine-tune 
these combinations on the sample, and identify fewer 
promising ones as the foundation for a further reduced 
search space several times. As the sample increases, the 
search space decreases. In the last round, we use the 
complete data set to identify an effective combination.
More specifically, our draft method proceeds in 
rounds. Each round uses two disjoint, random samples 
of the data set: the training sample and test sample. The 
training sample expands across rounds and doubles its 
size each round, while the test sample remains the same 
across rounds (Fig. 3). In the first round, we begin with a 
small training sample. For every machine learning algo-
rithm, we test both its default hyper-parameter value 
combination and a fixed number of random ones (e.g., 
20), if any. To test a combination, we first use the algo-
rithm and combination to train a model on the training 
sample, and then estimate the model’s accuracy on the 
test sample. Across all combinations tested so far for 
an algorithm, the highest accuracy achieved reflects the 
algorithm’s potential and is used to identify unpromising 
algorithms.
In each round after the first, for every remaining 
machine learning algorithm, we use a Bayesian optimiza-
tion approach [40] to select multiple new hyper-param-
eter value combinations, if any, for testing. To guide 
the search direction, a regression model is constructed 
to predict machine learning model accuracy based on 
hyper-parameter values [7, 9, 40, 41]. Removing irrel-
evant hyper-parameters from the regression model can 
make it more accurate, reduce tests needed for the search 
process, and expedite search. For this purpose, we build 
a separate regression model for each algorithm. Using 
the expected improvement criterion and a regression 
model for predicting combination quality, the Bayesian 
optimization approach selects two groups of new combi-
nations. The first group comes from local search around 
the 10 previously tested combinations with the larg-
est expected improvement. The second group is the 10 
combinations with the largest expected improvement 
from 10,000 random ones. Combinations in these two 
groups are interleaved for testing. Combinations in the 
first group tend to have better quality than those in the 
second group, as the regression model is better at pre-
dicting the quality of combinations close to previously 
tested ones [42]. To prevent search from being overly 
delayed on a single combination of an algorithm and 
hyper-parameter values, we impose a limit T on time that 
can be spent testing a combination. T is increased across 
rounds. Once T is exceeded, a test on a combination is 
stopped.
Our draft method needs improvement to perform sat-
isfactorily and to work well on a computer cluster. For 
efficiently and automatically selecting machine learning 
algorithms and hyper-parameter values, we use a new 
method that is based on the draft method and includes 
additional techniques for optimization and refinement to 
further improve efficiency. These techniques have never 
been used before for automating machine learning model 
selection.
Technique 1: Remove unpromising features early. Both 
existing automatic selection methods [7, 10, 37] and our 
draft method conduct many tests. Each test checks a fea-
ture selection technique, machine learning algorithm, 
and hyper-parameter value combination on (a subset 
of ) the data set. Since execution time of feature selection 
and model building grows at least linearly with the num-
ber of features, conducting the test is slow if the data set 
has many features. In this case, most features likely have 
low predictive power. Before conducting tests, we apply a 
fast feature selection technique such as the information 
gain method to (a sizeable sample of ) the complete data 
set and quickly remove features unlikely to be predictive. 
Then each test can use a slower feature selection tech-
nique for a finer examination of the remaining features.
Technique 2: Drop unpromising feature selection tech-
niques early. Our draft method builds a separate regres-
sion model for each machine learning algorithm to 
predict machine learning model accuracy based on 
hyper-parameter values. Separation helps make the 
regression model more accurate, but each regression 
model uses all hyper-parameters for feature selection, 
which are too many and reduce its accuracy.
Each feature selection technique uses a feature search 
method and feature evaluator [7]. The hyper-parame-
ters for feature selection include the choice of feature 
search method, the choice of feature evaluator, and Fig. 3 Progressive sampling used in our automatic selection method
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hyper-parameters for each feature search method and 
evaluator. To further reduce hyper-parameters used in 
each regression model, we conduct fast trials on small 
samples of the data set to remove as many unpromising 
feature evaluators as early as possible. Once a feature 
evaluator is removed, its hyper-parameters are dropped 
from all regression models thereafter. Also, it will not be 
used in the rest of the search process. This reduces the 
search space and tests needed for the search process. 
We remove feature evaluators over rounds until no more 
than a fixed number of feature evaluators (e.g., 4) remain. 
Feature search methods can be handled similarly. This 
technique can be applied to several other parts of a data 
analytic pipeline [43] such as handling missing values and 
imbalanced classes.
We identify and remove unpromising feature evalua-
tors similarly to our draft method identifies and removes 
unpromising machine learning algorithms. Our draft 
method proceeds in rounds. In each round, across all 
hyper-parameter value combinations tested so far for 
an algorithm, the highest accuracy achieved reflects the 
algorithm’s potential and is used to identify unpromising 
algorithms. Since the choice of feature evaluator is a hyper-
parameter, we draw the following analogy. Across all com-
binations of algorithms and hyper-parameter values tested 
so far for a feature evaluator, the highest accuracy achieved 
reflects the feature evaluator’s potential. However, unlike 
the case with algorithms, our draft method makes no 
guarantee about the number of tests done on each fea-
ture evaluator. Without sufficient tests, our estimate of 
a feature evaluator’s potential can be highly inaccurate. 
To address this issue, we modify our draft method. If the 
number of tests done on a feature evaluator is smaller than 
a fixed number (e.g., 20), we perform additional tests for 
the feature evaluator to make up the difference. Each addi-
tional test uses a random combination of an algorithm and 
hyper-parameter values and is fast to perform, as the train-
ing sample is small in the first round.
Technique 3: Improve the quality of combinations 
selected from random ones. As mentioned above, in each 
round after the first, for every remaining machine learn-
ing algorithm, our draft method selects two groups of 
new hyper-parameter value combinations for testing. 
Combinations in the first group tend to have better qual-
ity than those in the second group. If we can improve 
combination quality in the second group, we can improve 
the final search result’s quality. Or, we can reduce tests 
for later rounds and improve search speed.
Our draft method doubles the training sample size each 
round. To improve the quality of hyper-parameter value 
combinations in the second group, we conduct fast tri-
als on small samples of the data set to identify unprom-
ising combinations. Starting from the third round when 
the training sample is no longer small, we select the 30 
combinations with the largest expected improvement 
from 10,000 random ones. Each of the 30 combinations is 
tested on the training sample from the first rather than the 
current round. Each test is fast to perform, as the training 
sample from the first round is small. Among the 30 com-
binations, the 10 achieving the highest accuracies tend to 
have better quality than the other 20 and form the second 
group. For each of the other 20 combinations, we use the 
scaling technique in our paper [17] to perform scaling for 
each round and obtain a rough accuracy estimate for the 
combination for the current round. In this way, without 
wasting any test results, all 30 combinations are used for 
building the regression model in later rounds.
Technique 4: Automatically build an ensemble model 
from models constructed during the search process. The 
search process produces many machine learning models. 
Once complete, we use the approach in Caruana et  al. 
[44] to automatically build an ensemble model from these 
models with low overhead. The ensemble model is often 
more accurate than individual models and can serve as 
the final model. Feurer et al. [37] used a similar method 
to form an ensemble model after the search process, but 
limited the search process to base models, affecting accu-
racy of models produced during it. In contrast, we use a 
novel approach that has no such restriction and produces 
an ensemble model likely to be more accurate. Almost 
all of the models produced during our search process are 
trained using parts of the data set, while model accuracy 
generally improves with a larger training set. To further 
improve our ensemble model’s accuracy, we can use the 
whole data set to train a few of the most accurate models 
to make them even more accurate.
Technique 5: Parallelize the tests in the first few rounds of 
the search process. Our draft method performs tests sequen-
tially. To speed up the search process, we can parallelize the 
tests in the first few rounds, and then switch to parallelize 
data processing for each test one by one in later rounds. Our 
discussion focuses on the case that PredicT-ML runs on a 
cluster of computers. The case that PredicT-ML runs on a 
computer with multiple processing units (e.g., processors or 
processor cores) can be handled similarly.
Our draft method proceeds in rounds. Except for the 
final one, each round tests multiple combinations of 
machine learning algorithms and hyper-parameter values 
one by one. The training sample expands across rounds. 
In each of the first few rounds, the training sample is 
small. Partitioning it across all computers and using each 
combination to train a model on all computers concur-
rently will incur excessive communication overhead. To 
use parallel processing well, we test different combina-
tions on different computers concurrently.
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We choose a positive integer m (e.g., 3)  <  the total 
number of rounds. m’s value increases with the search 
space size partly reflected by the number of machine 
learning algorithms. Before starting, we distribute a copy 
of both the training sample for the m-th round and the 
test sample to each computer. The training sample for the 
m-th round is a super set of that for each earlier round. 
Thus, in each of the first m rounds, a copy of both the 
training sample for the current round and the test sample 
is available on each computer. All combinations of algo-
rithms and hyper-parameter values to be tested are put 
into a queue [45]. When a computer becomes available, 
the first combination is removed from the queue and sent 
to the computer for testing. In this way, all combinations 
are partitioned across all computers roughly evenly for 
concurrent testing.
Starting from the (m + 1)-th round, the training sam-
ple becomes large. Communication overhead is no longer 
excessive. Also, the number of combinations of machine 
learning algorithms and hyper-parameter values to be 
tested in each round becomes small. In this case, we can 
no longer use the power of parallel processing well by 
testing different combinations on different computers 
concurrently. For example, some computers will stay idle 
if a specific round has fewer combinations to test than 
computers. Before starting the (m + 1)-th round, we par-
tition the whole data set evenly across all computers, if 
not done before. Starting from the (m + 1)-th round, the 
training sample is already partitioned across all comput-
ers. We test combinations one by one and use each com-
bination to train a model on all computers concurrently.
If the cluster has many computers, in the (m +  1)-th 
round the training sample is no longer small, but parti-
tioning it across all computers will still incur excessive 
communication overhead in model training. To use par-
allel processing well, we add one or more intermediate 
transition stages between rounds. In each round of such a 
stage, all computers are partitioned into multiple subsets. 
Different combinations of machine learning algorithms 
and hyper-parameter values are tested on different sub-
sets. For each combination, we train a model on all com-
puters in its corresponding subset concurrently.
Technique 6: Skip overly time-consuming tests. Our draft 
method imposes a limit T on time that can be spent test-
ing a combination of a machine learning algorithm and 
hyper-parameter values. Once T is exceeded, a test on a 
combination is stopped, often with no accuracy recorded 
and time spent on the test wasted. In practice, multiple 
good combinations achieving similar accuracies often 
exist. Some can be tested much more quickly than oth-
ers, and finding any of them would serve our purpose. To 
avoid wasting time on overly time-consuming tests, we 
predict the time needed for a test and skip tests unlikely 
to finish within T. We use a fixed factor f > 1 to tolerate 
some imprecision in prediction. If the predicted test time 
for a combination is > f × T, we regard the combination 
as unlikely to finish within T and skip it. By spending the 
time testing other combinations likely to finish within T, 
we can obtain accuracy results for more combinations 
within the same total time. This can improve the final 
search result’s quality or expedite our search process.
We use the following method to predict the test time 
for a combination of a machine learning algorithm and 
hyper-parameter values. Our discussion focuses on 
model training time. Feature selection time can be han-
dled similarly. For each algorithm, its default hyper-
parameter value combination is tested in the first round. 
The test time serves as the baseline. We model the ratio 
of the amount of time for each other test to the baseline 
as the product of two ratios, one for training sample size 
and another for the algorithm’s hyper-parameter values. 
The formula describing the relationship between train-
ing sample size and model training time is known for 
many algorithms and used to compute the ratio for train-
ing sample size. For each other algorithm, we use results 
from previous machine learning problems to build a 
regression model for that ratio.
For estimating the ratio for a machine learning algo-
rithm’s hyper-parameter values, we compare two 
approaches and pick the more accurate one for each 
algorithm. The first approach is to build a random forest 
model that can deal with both continuous and categorical 
hyper-parameters. In comparison, Snoek et  al. [9] used 
a Gaussian process to predict the test time for a hyper-
parameter value combination. That approach cannot 
handle categorical hyper-parameters or a training sample 
that expands across rounds. The second approach is to 
compute this ratio as the product of multiple ratios, one 
for each hyper-parameter’s value. For a hyper-parameter 
known to impact model training time little, we set the 
ratio for its value at one. For a hyper-parameter with a 
known formula describing the relationship between its 
value and model training time, we use the formula to 
compute the ratio for its value. For each other hyper-
parameter, we use results from previous machine learn-
ing problems to fit a (e.g., power) function for the ratio 
for its value. Or, we can specifically treat the categorical 
hyper-parameters known to greatly impact model train-
ing time. For each combination of their values, we make a 
separate fit of functions for the ratios for the other hyper-
parameters’ values.
Technique 7: Delay time-consuming tests to the end of 
the search process. Certain hyper-parameters of some 
machine learning algorithms are known to have a spe-
cial property. Setting the hyper-parameter to a value in 
a specific range, often in a specific direction, is likely to 
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improve model accuracy at the expense of much slower 
model training. An example of such hyper-parameters is 
the number of decision trees in a random forest. A ran-
dom forest is an ensemble of decision trees. Using many 
decision trees often improves model accuracy, but model 
training time increases proportionally with the number 
of decision trees. To ensure the search process can test 
many combinations of algorithms and hyper-parameter 
values within reasonable time, we cannot afford testing 
hyper-parameter values in such ranges during the search 
process. However, we can do such tests at the end of the 
search process when model training time is no longer 
a major issue. For the top few algorithms achieving the 
highest accuracies and with the special property, we start 
another search process based on the most accurate mod-
els built using them, test their hyper-parameter values 
in such ranges, and try to use them to build even more 
accurate models. This can improve the final model’s accu-
racy without affecting accuracies of the models built dur-
ing the first search process. In the second search process, 
if we know that changing a numerical hyper-parameter’s 
value in a specific direction is likely to improve model 
accuracy, we can move in that direction until we have 
confidence in convergence [39]. That is, model accuracy 
no longer improves (much) as the hyper-parameter’s 
value changes in that direction.
A method to efficiently automate selection of temporal 
aggregation periods and operators for clinical attributes
Manually specifying temporal aggregation periods and 
operators is labor-intensive and time-consuming. Our 
idea for automating temporal aggregation on a clini-
cal attribute is to list temporal aggregation periods and 
operators that can be clinically meaningful, enumerate all 
aggregation period and operator pairs, then conduct fea-
ture selection to select one or more most predictive pairs. 
Our automation method requires disease-specific knowl-
edge compiled by clinical experts and stored in PredicT-
ML. Knowledge can be added over time and does not 
have to be comprehensive or precise for PredicT-ML to 
be useful. PredicT-ML can function once some aggrega-
tion operators are compiled. For selecting aggregation 
periods, the shortest and longest possible ones serv-
ing as search ranges can be specified conservatively. A 
crowd sourcing approach can be adopted for compiling 
knowledge.
We demonstrate our techniques by compiling knowl-
edge for asthma and type 2 diabetes. We start from com-
monly used aggregation operators and clinical attributes 
related to these two diseases. In the future, we plan to (1) 
compile additional knowledge for these two diseases to 
cover more aggregation operators and clinical attributes, 
(2) compile knowledge for other diseases so PredicT-ML 
can automate temporal aggregation for them, and (3) 
add an interface allowing users to input knowledge into 
PredicT-ML. PredicT-ML can automate temporal aggre-
gation for a new disease and prediction target pair once 
knowledge is input for it.
Compile knowledge
By combining our medical knowledge, our extensive 
experience building clinical predictive models, literature 
on clinical predictive modeling [46, 47] and temporal pat-
tern mining [48, 49], and experience of colleagues at the 
University of Utah, we compile a list of commonly used 
temporal aggregation operators such as in the aggrega-
tion period: (1) the clinical attribute’s minimum/maxi-
mum/average value, (2) whether the clinical attribute 
(e.g., a disease diagnosis code) appears, (3) the duration 
of using the clinical attribute (e.g., a medication), (4) 
the count of the clinical attribute (e.g., hospitalization), 
(5) whether the clinical attribute’s value (e.g., weight) is 
monotonically increasing/decreasing, (6) the clinical 
attribute’s most recent value, (7) the (relative) change 
in the clinical attribute’s value, (8) the percentage of the 
clinical attribute’s values (e.g., lab test results) that are 
high/low/normal/equal to a given value, (9) whether the 
quarterly/monthly/weekly frequency of having the clini-
cal event (e.g., doctor visits) is monotonically increasing/
decreasing, and (10) whether a medication’s use is inten-
sified/de-intensified. We implement all of the operators 
on Spark that currently do not exist.
Suitable temporal aggregation periods and operators 
vary by diseases, prediction targets, and clinical attrib-
utes. Many combinations of diseases, prediction targets, 
and clinical attributes exist. Our automation method 
needs knowledge for each combination. Given limited 
resources, we use a grouping technique to reduce efforts 
needed for compiling knowledge. Instead of compiling 
knowledge for each combination, we partition combina-
tions into groups and compile knowledge for each group.
Consider the targeted diseases for which we want Pre-
dicT-ML to automate temporal aggregation. We check 
the clinical predictive modeling literature and find com-
monly used prediction targets for targeted diseases, as 
we did for bronchiolitis [50]. The clinical experts in our 
research team use their expertise and reference grouper 
models such as the Clinical Classifications Software 
(CCS) system [51, Chapter 5] to group prediction targets 
with similar properties and repeatedly recorded clini-
cal attributes with similar properties. For each poten-
tially related combination of a disease, prediction target 
group, and clinical attribute group, our clinical experts 
select suitable temporal aggregation operators from our 
list, partition them into categories, and pick the shortest 
and longest, clinically meaningful temporal aggregation 
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period and a progression method for each category. The 
progression method specifies how to automatically gen-
erate a sequence of candidate aggregation periods. In an 
exponential progression method, we start from the short-
est aggregation period and elongate the period’s length 
exponentially (e.g., by doubling) until we reach the limit 
allowed by the longest aggregation period. In an arith-
metic progression method, in each step we elongate the 
period’s length by a constant.
Temporal aggregate values are used as features to build 
predictive models, where features containing non-redun-
dant information are generally preferred [52]. To facili-
tate this, we partition temporal aggregation operators 
into categories. The operators in the same and different 
categories produce relatively redundant and non-redun-
dant aggregate values, respectively. For a clinical attrib-
ute, our automation method produces an aggregate value 
from each category of operators rather than from each 
individual operator. The aggregate values from different 
categories provide non-redundant information that can 
help increase model accuracy. For instance, for a patient’s 
weight, two non-redundant aggregate values are (1) the 
average weight and (2) whether the patient’s weight is 
monotonically increasing in the aggregation period. Two 
relatively redundant aggregate values are the change and 
relative change in a patient’s weight in the aggregation 
period.
Many combinations of a disease, prediction target 
group, and clinical attribute group exist. It is non-trivial 
to compile knowledge for each combination. However, 
knowledge overlaps across different combinations. For 
example, for the same clinical attribute group, aggre-
gation periods and operators overlap for different dis-
eases. Compilation time for each new combination 
will decrease as compiled knowledge is applied to new 
combinations.
Select temporal aggregation periods and operators
Given a disease, prediction target, and medical data set, 
we use a feature selection technique to automate tem-
poral aggregation on clinical attributes. We identify the 
prediction target group including the prediction target. 
For each clinical attribute in both the medical data set 
and a clinical attribute group related to the disease and 
prediction target group, we automatically select one tem-
poral aggregation operator from each related operator 
category, and a temporal aggregation period between the 
shortest and longest ones linking to the category.
To do this, we generate a sequence of temporal aggre-
gation periods between the shortest and longest periods 
based on the progression method linking to the aggre-
gation operator category. We list all operators in the 
category and all aggregation period and operator pairs. 
On a large sample of the whole data set, we use each 
pair to compute an aggregate value feature of the clini-
cal attribute, then apply a feature selection technique [52] 
such as the information gain method to select the feature 
most predictive of the prediction target. The pair link-
ing to this feature is used to compute this feature on the 
whole data set. Finally, we use Spark SQL [32, 33] to join 
the selected aggregate value features with non-repeat-
edly recorded clinical attributes. Basically, our method 
selects one feature from each feature group. This is dif-
ferent from the traditional methods of selecting features 
with group structures [52], where multiple features in the 
same group tend to be selected or not selected together 
with no limit imposed on the number of features selected 
from any single group. The selected aggregate value fea-
tures are stored in the Hadoop distributed file system, 
Spark’s default persistent storage space. In PredicT-ML’s 
input interface, the user can modify their storage loca-
tion, e.g., to export them to CSV format for use by other 
programs.
Repeatedly recorded clinical parameters are often 
stored in the EAV (Entity-Attribute-Value) format [17, 
18], which uses tables including at least three parts: the 
entity, attribute, and value (Fig.  4). Typically, the entity 
combines patient ID and timestamp and identifies a 
clinical event [14, p. 58]. The attribute identifies a clini-
cal parameter. The value includes the clinical parameter’s 
value. As a result, an EAV table merges numerous clini-
cal parameters and their values in the attribute and value 
parts. We use MapReduce [20] to compute all temporal 
aggregate value features together on Spark. The Map 
function forms one key-value pair per EAV tuple. The key 
is the patient ID in the EAV tuple. The value combines the 
attribute, timestamp, and value in the EAV tuple. In the 
Map function, EAV tuples corresponding to unused clini-
cal parameters are removed early on [19]. For a patient 
ID, the Reduce function merges all relevant EAV tuples 
with the patient ID from one or more EAV tables, collects 
all (timestamp, value) pairs for each clinical parameter, 
computes each aggregate value feature of every clinical 
parameter, and combines all aggregate value features into 
a relational tuple.
Different medical data sets use different schemas, med-
ical terminologies, and medical coding systems, creating 
difficulty in using pre-compiled knowledge. To address 
this issue, PredicT-ML’s automated temporal aggrega-
tion function requires the medical data set excluding the 
prediction target to conform to the OMOP common data 
model [16] and its associated standardized terminolo-
gies [53]. As this data model standardizes administrative 
and clinical attributes from at least 10 large healthcare 
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systems in the U.S. [54], PredicT-ML can be used on 
medical data sets from these systems. In the future, we 
plan to add support for the i2b2 [55] and PCORnet com-
mon data models [56] into PredicT-ML.
Our above discussion focuses on the case that each aggre-
gation operator acts on one clinical attribute without using 
any other parameter beyond the aggregation period. The 
case that an aggregation operator acts on >1 clinical attrib-
ute and/or uses other parameters beyond the aggregation 
period can be handled similarly, e.g., by enumerating values 
for the other parameters. An example of such aggregation 
operators is whether a given medication (e.g., fluconazole) 
was prescribed in a certain period before an abnormal result 
of a given (e.g., liver function) lab test occurred, reflecting 
the knowledge of this side effect. Here, the medication and 
lab test result are two clinical attributes. The threshold for 
the time gap between the medication’s prescription and the 
abnormal lab test result’s occurrence is a parameter beyond 
the aggregation period. Two other examples of such aggre-
gation operators are whether medications are switched and 
whether multiple therapies are used.
Also, our above discussion focuses on the case that 
the medical data set includes exactly one prediction tar-
get instance per patient. The case that on some or all 
patients, the medical data set includes more than one 
prediction target instance per patient can be handled 
similarly. There, each prediction target instance of a 
patient corresponds to a different time point, for which 
a separate set of temporal aggregate values will be com-
puted. For example, suppose we have 5  years’ data on 
each patient. Our goal is to use the previous 3 years’ data 
to predict acute care use within the next year. For pre-
dicting acute care use within year 4, data in years 1–3 are 
used to compute temporal aggregate values. For predict-
ing acute care use within year 5, data in years 2–4 are 
used to compute temporal aggregate values.
A method to project in real time model accuracy 
and estimated outcomes of using models as a function 
of time allocated for model building
To be more user-friendly and useful, during the auto-
matic model selection process, PredicT-ML displays 
projections of model accuracy and estimated patient 
outcomes of using models as a function of time allotted 
for model building (Fig. 5). At any time among all mod-
els built thus far, the one obtaining the best accuracy is 
used to obtain model accuracy and estimated outcomes 
of using the best model for the current point in time. As 
the process proceeds, the projections are continuously 
refined to become more precise.
The highest model accuracy achieved by PredicT-ML 
increases over time, whereas the rate of increase typically 
decreases over time (Fig. 5). To model the highest model 
accuracy achieved over time, we use an inverse power 
law function of the form f(t) = a − b × t−c [57]. Here, t 
denotes time, 0 < b < a < 1, and c > 0. The inverse power 
Fig. 4 Use MapReduce to obtain temporal aggregate values of two clinical parameters ‘test 1’ and ‘test 2’
Fig. 5 The highest model accuracy achieved by PredicT-ML over time
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law function has been used before to model the relation-
ship between model accuracy and training set size [57]. In 
our case, the function is re-fitted from time to time to pro-
ject model accuracy vs. time allotted for model building.
More specifically, each time PredicT-ML builds a pre-
dictive model during the automatic model selection 
process, we obtain a training data point of time and the 
highest model accuracy achieved. We use the training 
data points obtained so far to fit the inverse power law 
function in a way similar to that in Figueroa et  al. [57]. 
Our goal of fitting the function is to predict the future 
as precisely as possible. Our goal is not to minimize 
the average distance between all training data points 
obtained so far, which represent the past, and the fit-
ted curve. In general, the training data points obtained 
later reflect the trend into the future better than those 
obtained earlier. Based on this insight, we give larger 
weights to the training data points obtained later rather 
than treating all training data points equally. We fix a 
positive integer g (e.g., 20). Let h represent the number 
of training data points obtained so far. When fitting the 
function, we consider only the last n = min(g, h) training 
data points and give a weight of i/n to the i-th of the n 
data points [57].
For a future time point, we use a method similar to 
the one in our papers [1, 58] to obtain projections of 
estimated outcomes of using predictive models. Our 
discussion focuses on a categorical prediction target. 
Continuous prediction targets can be handled similarly 
through discretization. We compute the percentage of 
instances qc in each category c of the prediction target. 
For each category pair (c1, c2), the user of PredicT-ML 
specifies the outcome oc1,c2 (e.g., cost) when an aver-
age instance (e.g., patient) in c1 is predicted to be in c2 
and interventions are decided based on the prediction 
result. We use a function fitting approach similar to the 
one above to project pc1,c2, the percentage of instances 
in c1 that the best model at this time point will predict 
to be in c2. When c1  =  c2, pc1,c2 reflects accuracy and 
tends to increase over time. Thus, a function of the form 
f(t) = a − b ×  t−c is used. When c1 ≠   c2, pc1,c2 reflects 
error rate and tends to decrease over time. Thus, a func-
tion of the form f(t) = a + b × t−c is used, where b is >0 
but not necessarily < a. The estimated outcome of using 
the best model at this time point is projected to be ∑
c1,c2
qc1 · pc1,c2 · oc1,c2, where qc1 · pc1,c2 is the expected 
percentage of instances that are in c1 and will be pre-
dicted to be in c2.
Preliminary results
Recently, we did an initial implementation and perfor-
mance evaluation of our draft method for automatically 
selecting machine learning algorithms and hyper-parame-
ter values [17] on a single computer. Compared to the state 
of the art Auto-WEKA automatic selection method [7], on 
21 prominent machine learning benchmark data sets, on 
average our draft method reduced (1) search time by nine-
fold, (2) classification error rate by 14 % and (3) standard 
deviation of error rate due to randomization by 26  %. A 
detailed report of our initial implementation and prelimi-
nary results is available in our paper [38]. At present, we 
are still in the process of tuning our draft method. PredicT-
ML’s automatic machine learning model selection function 
is based on our draft method. Thus, we will not be able to 
start building PredicT-ML until we have finished tuning 
our draft method, integrated it with MLlib and distribut-
edWekaSpark’s machine learning functions, and imple-
mented it on top of Spark on a computer cluster, which 
will take quite some time.
Evaluation plan
PredicT-ML is a large software system that will take sev-
eral years to be fully built. This section presents our eval-
uation plan for PredicT-ML. We will evaluate each of the 
three methods described above.
Demonstration test cases
For evaluating each of the three methods, we will use the 
same three test cases, where PredicT-ML will be used to 
build models to predict asthma outcomes and risk for 
type 2 diabetes. PredicT-ML can be used for other dis-
eases and prediction targets. We choose these test cases 
based on the following criteria: the data sets are read-
ily accessible, the addressed diseases are common, both 
categorical and continuous prediction targets are cov-
ered, and resulting predictive models can potentially be 
deployed to impact care delivery. Asthma and type 2 dia-
betes each have a prevalence of 9 % [59–62] and account 
for significant healthcare use and cost [1, 4]. Accurate 
prediction of asthma outcomes and risk for type 2 diabe-
tes helps target preventive interventions to appropriate 
patients to improve health outcomes and reduce costs 
[1, 4]. For example, each year asthma incurs 439,000 hos-
pitalizations, 1.8 million emergency department visits, 
3630 deaths [61], and 56 billion dollars in cost [63]. Case 
management for the right asthma patients can lower cost 
by up to 15  % and reduce emergency department visits 
and hospital (re)admissions by up to 30–40 % [64–70].
Computing environment All experiments will be per-
formed on the HIPAA-compliant Homer computer 
cluster at the University of Utah [71]. With appropriate 
authorization, all members in our research team at the 
University of Utah can access this cluster using univer-
sity computers. Our analysis results will form a base to 
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expand testing of PredicT-ML on other clinical data sets 
and test cases in the future.
Test case 1: predict acute care use in asthmatic children 
within the next year 
Patient population Intermountain Healthcare patients 
in the past 11 years with asthma, identified by the method 
in Schatz et al. [72–74] as having (1) at least one ICD-9 
diagnosis code of asthma (493.xx) or (2)  ≥  2 “asthma-
related medication dispensings (excluding oral steroids) 
in a one-year period,” “including β-agonists (excluding 
oral terbutaline), inhaled steroids, other inhaled anti-
inflammatory drugs, and oral leukotriene modifiers” [72]. 
Intermountain Healthcare has 22 hospitals and 185 clin-
ics and is the biggest healthcare system in Utah.
Data set The Intermountain Healthcare enterprise data 
warehouse contains a large set of attributes and  ~9000 
tables [75]. On an encrypted and password-protected 
computer cluster, we will conduct secondary analysis of 
a large, de-identified, administrative and clinical data set 
obtained from the Intermountain Healthcare enterprise 
data warehouse. The data set includes information about 
patient encounters in the previous 11 years. For the most 
recent 5 years, data captured cover ~27,000 children (age 
0–17) and ~75,000 adults (age ≥18) with asthma per year. 
The data set has ~400 attributes partly listed in our paper 
[1] and is the electronic record of about 85 % of pediatric 
care and about 60 % of adult care provided in Utah [76, 
77]. Identifying asthma requires prescription and refill 
information. Our data set has this information because 
Intermountain Healthcare uses its own health insurance 
plan called SelectHealth. If too many refill records are 
missing from the Intermountain Healthcare enterprise 
data warehouse, we will compensate using claim data 
from the all-payer claims database [78].
Information about the predictive models Administrative 
and clinical attributes will be used to construct models. 
The prediction target (i.e., dependent variable) is whether 
acute care (emergency department visit, urgent care, and 
inpatient stay) with a primary diagnosis of asthma (ICD-9 
code: 493.xx) happened to an asthmatic child in the fol-
lowing year [1, 72, 79]. We will use the first 10 years’ data 
to build models and the 11-th year’s data for testing to 
obtain the final accuracy estimate of a model, reflect-
ing use in practice. The standard area under the receiver 
operating characteristic curve (AUC) [5] performance 
metric will be used. We will adopt standard techniques, 
e.g., imputation to deal with missing values and iden-
tify and remove/correct invalid values [2, 80]. We will 
adopt grouper models such as the CCS system to group 
drugs, procedures, and diseases and reduce features [51, 
Chapter 5].
Test case 2: predict individual patient cost in  asthmatic 
adults within the next year 
Test case 2 differs from test case 1 in the following 
ways. The prediction target is an asthmatic adult’s total 
cost in the following year [51, 81]. Each medical claim 
links to a billed cost, an Intermountain-internal cost, and 
a reimbursed cost [51, p. 43]. We will use the Intermoun-
tain-internal cost [77], which is less subject to variation 
resulting from member cost-sharing [51, p. 45] and more 
closely reflects actual cost. To address inflation, we will 
use the medical consumer price index [82] to standard-
ize all costs to 2015 dollars. The standard R2 performance 
metric will be used [81].
Test case 3: predict type 2 diabetes diagnosis in  adults 
within the next year 
Patient population and data set We have used the clini-
cal and administrative data set from the Practice Fusion 
diabetes classification competition [13]. The data set is 
publicly available and de-identified. It includes both his-
torical 3-year records (2009–2012) and the next year’s 
labels of 9948 adult patients in all 50 states in the United 
States. In the next year, 1904 of these patients were 
diagnosed with type 2 diabetes. The data set contains 
information on patient demographics, allergies, immu-
nizations, diagnoses, lab results, smoking status, medica-
tions, and vital signs.
Information about the predictive models The predic-
tion target is whether a patient had type 2 diabetes diag-
nosis in the following year. We will randomly choose 2/3 
of patients as the training set to build models and use 
the other 1/3 as the test set to evaluate a model’s perfor-
mance. Other details mirror test case 1.
Performance evaluation of our method for automatically 
selecting machine learning algorithms and hyper‑parameter 
values
We will implement in PredicT-ML and then com-
pare our method and the state of the art Auto-WEKA 
method for automatically selecting machine learn-
ing algorithms and hyper-parameter values [7]. We 
will perform temporal aggregation of clinical attrib-
utes manually for both methods, as the Auto-WEKA 
method cannot automate temporal aggregation. We 
will allow the Auto-WEKA method to test 1000 com-
binations of algorithms and hyper-parameter values, 
which according to our experience is essential to find an 
effective combination. We will test the hypothesis that 
our method will produce models with equal or higher 
accuracy (AUC or R2) in ≤1/20 of the time taken by the 
Auto-WEKA method. We will regard this part of the 
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study partly successful if the hypothesis is confirmed for 
two test cases, and completely successful if confirmed 
for all three test cases.
For test case 1, consider the categorical prediction 
target of acute care usage with two values (classes). A 
model for this prediction target usually achieves an 
AUC far below 0.8 [72, 83]. Using a one-sided Z-test at 
a significance level of 0.05 and assuming for both classes 
a correlation coefficient of 0.6 between the prediction 
results produced by our method and the Auto-WEKA 
method, a sample size of 1305 instances per class has 
90 % power to conclude that with an equivalence mar-
gin of 3  %, our method produces no worse AUC than 
the Auto-WEKA method. The 11th year’s data include 
about 27,000 children with asthma, providing adequate 
power to test our hypothesis. The cases with test cases 2 
and 3 are similar.
Performance evaluation and sample size justification for our 
automated temporal aggregation method
We will test the hypothesis that our automated temporal 
aggregation method will produce more accurate models 
than a clinical expert. A clinical and medical informat-
ics expert in our research team will convert all medical 
data sets into the OMOP common data model format 
and its associated standardized terminologies. For each 
test case, we will use PredicT-ML to automatically select 
machine learning algorithms and hyper-parameter values 
and compare the accuracies achieved by two predictive 
models. The first model will be built using our automated 
temporal aggregation method. The second model will 
be built with this expert in our research team specifying 
temporal aggregation periods and operators for up to 20 
trials. To avoid potential evaluation bias, this expert will 
not participate in compiling knowledge for PredicT-ML. 
We will accept the hypothesis if the first model attains 
higher accuracy (AUC or R2) than the second model 
by ≥5 %. We will regard this part of the study partly suc-
cessful if the hypothesis is confirmed for two test cases, 
and completely successful if confirmed for all three test 
cases.
For test case 1, consider the categorical prediction 
target of acute care usage that has two values (classes). 
A model for this prediction target typically achieves an 
AUC well below 0.8 [72, 83]. Assuming for both classes 
a correlation coefficient of 0.6 between the prediction 
results of the two models and using a two-sided Z-test 
with a significance level of 0.05, a sample size of 561 
instances per class has 90 % power to identify a difference 
of 0.05 in AUC between the two models. The 11th year’s 
data incorporate about 27,000 children with asthma, giv-
ing adequate power to test our hypothesis. The cases with 
test cases 2 and 3 are similar.
Performance evaluation of our method for projecting model 
accuracy
For the same prediction target, the outcome can differ 
by the specific healthcare application. Hence, our testing 
focuses on model accuracy rather than estimated out-
comes of using models. In projecting model accuracy vs. 
training set size, the inverse power law model typically 
produces a root mean squared error <2 % [57]. The high-
est model accuracy achieved by PredicT-ML vs. time 
follows a similar trend as model accuracy vs. training 
set size. Hence, we would expect the inverse power law 
model to produce reasonable projection accuracy in our 
case. Our goal is that after  ≤1  h, our projected model 
accuracy (AUC or R2) for the next 3  days or until the 
automatic model selection process finishes, whichever is 
first, will differ from the actual accuracy by ≤3 % in root 
mean squared error [57]. We will regard this part of the 
study partly successful if the goal is reached for two test 
cases, and completely successful if reached for all three 
test cases.
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Conclusions
We describe the design of PredicT-ML, a software sys-
tem that automates building machine learning pre-
dictive models with big clinical data, with continuous 
feedback to users to help them decide whether they 
should continue the automatic model building process 
or consider other modeling options. PredicT-ML can 
(1) efficiently automate selection of machine learning 
algorithms and hyper-parameter values, (2) efficiently 
automate selection of temporal aggregation periods and 
operators for clinical attributes, and (3) in real time, dis-
play projected model accuracy and estimated patient 
outcomes of using models as a function of time allotted 
for model building. PredicT-ML will open the use of big 
clinical data to thousands of healthcare administrators 
and researchers, and boost the ability to advance clini-
cal research and improve healthcare. We are currently 
in the process of writing a detailed design document of 
PredicT-ML.
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